Impact Biomedical Inventory Turnover Ratio (COS)

Cost of Sales Formula, Quarterly Results, Trends, Rankings, Statistics

Impact Biomedical Inc. inventory turnover ratio, the Impact Biomedical Inc.'s ability to sell and replace its inventory in the second quarter 2026, sequentially increased to 2.46 in the second quarter 2026, a new company high. Average inventory processing period, for the Impact Biomedical in Jun 30 2026 quarter, has decreased to 148 days, compare to 235 days, in the Mar 31 2026 quarter.

Within Healthcare sector IMPACT BIOMEDICAL INC. achieved the highest inventory turnover ratio. While in terms of ranking among all other companies, the company has moved form 1673 in the first quarter 2026, to 1679.

IBO Inventory Turnover Ratio using Sales Formula
What is Inventory Turnover Ratio?
What is Impact Biomedical Inc. Market Share?

What is Inventory Turnover Ratio?

Select the Comparisons :

None ▼

Select the Ratio:

Inventory Turnover▼

None ▼

Inventory Turnover▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

IBO Inventory Turnover Ratio	(Jun 30 2026) II. Quarter	(Mar 31 2026) I. Quarter	(Dec 31 2025) IV. Quarter	(Sep 30 2025) III. Quarter	(Jun 30 2025) II. Quarter
Y / Y Inventory Growth	-87.24 %	-87.12 %	-	-	-
Y / Y Cost of Sales Growth	-90.91 %	-	-	-	-
Inventory Turnover Ratio (TTM)	2.46	-	1.11	0.03	0.05
IBO's Total Ranking	# 1679	# 1673	#	#	#
Average inventory processing period	148	-	328	11102	8088
Seq. Inventory Growth	-1.59 %	0 %	-87.01 %	-0.21 %	-0.61 %
Seq. Cost of Sales Growth	-	-	41100 %	-90.91 %	-

Inventory Turnover Ratio Company Ranking
Within:	No.
Major Pharmaceutical Preparations Industry	#
Healthcare Sector	#
Overall Market	# 1679

Inventory Turnover Ratio Statistics
High	Average	Low
2.46	1.71	1.11
(Jun 30 2026)		(Dec 31 2025)

IBO Company Profile >> Back to IBO Efficiency Comparisons >> Compare IBO Inventory Turnover Ratio to its Competitors

Financial Statements
Impact Biomedical's Inventories	$ 0 Millions	Visit IBO's Balance sheet
Impact Biomedical's Cost of Revenues TTM	$ 0 Millions	Visit IBO's Income Statement
What are IBO's Sales?		Visit IBO's Sales by Segment

Other Inventory Turnover Ratios
Impact Biomedical's Inventory to Sales Ratio
U.S. Durable Goods Inventory to Shipment Ratio By Product
Major Pharmaceutical Preparations Industry Inventory Turnover Trends and Statistics
Healthcare Sector Inventory Turnover Statistics
Inventory Turnover Trends for overall market
IBO's Inventory Turnover Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Inventory Turnover
Lowest Ranking Inventory Turnover
Inventory Turnover for IBO's Competitors
Inventory Turnover Ratio for IBO's Suppliers
Inventory Turnover Ratio for IBO's Customers

You may also want to know
IBO's Sales Growth Rates	IBO's Pe Price to earnings ratio	IBO's Receivables Turnover Ratio	IBO's Stock Quote
IBO's Net Income Growth Rates	IBO's Ps Price to Sales ratio	IBO's Sales per Employee	IBO's Asset Turnover Ratio
IBO's Net Margin	IBO's Pb Price to Book ratio	IBO's Financial Strength Ratios	IBO's Dividend Payout Ratio

Companies with similar Inventory Turnover Ratio for the quarter ending Jun 30 2026, within Healthcare Sector	Inventory Turnover Ratio	Cost of revenues at quarter ending Jun 30 2026	Inventories at quarter ending Jun 30 2026
Precipio inc	18.05	$ 15.200 Millions	$ 1 Millions
Rockwell Medical inc	17.36	$ 57.537 Millions	$ 3 Millions
Catheter Precision Inc	14.83	$ 1.001 Millions	$ 0 Millions
Agape Atp Corporation	14.52	$ 0.413 Millions	$ 0 Millions
Edap Tms Sa	12.79	$ 62.351 Millions	$ 5 Millions
Earth Science Tech Inc	11.64	$ 8.974 Millions	$ 1 Millions
Infusystem Holdings Inc	10.92	$ 60.985 Millions	$ 6 Millions
Natera Inc	9.46	$ 672.186 Millions	$ 71 Millions
Hims and Hers Health Inc	9.23	$ 814.411 Millions	$ 88 Millions
Polomar Health Services, Inc.	8.80	$ 1.233 Millions	$ 0 Millions
Myriad Genetics Inc	8.31	$ 250.700 Millions	$ 30 Millions
National Vision Holdings Inc	8.26	$ 841.416 Millions	$ 102 Millions
Inogen Inc	7.51	$ 196.617 Millions	$ 26 Millions
Moderna Inc	7.50	$ 1,707.000 Millions	$ 228 Millions
Adaptive Biotechnologies Corporation	7.26	$ 75.254 Millions	$ 10 Millions
Adm Tronics Unlimited Inc	6.05	$ 1.970 Millions	$ 0 Millions
Sharps Technology Inc	5.68	$ 2.869 Millions	$ 1 Millions
Transmedics Group Inc	5.59	$ 276.120 Millions	$ 49 Millions
Opko Health Inc	5.42	$ 348.206 Millions	$ 64 Millions
Charles River Laboratories International inc	5.39	$ 1,761.363 Millions	$ 327 Millions
Tactile Systems Technology Inc	5.12	$ 81.349 Millions	$ 16 Millions
Integer Holdings Corporation	5.03	$ 1,369.168 Millions	$ 272 Millions
Harrow Inc	4.93	$ 73.636 Millions	$ 15 Millions
Veracyte Inc	4.84	$ 102.741 Millions	$ 21 Millions
West Pharmaceutical Services Inc	4.72	$ 2,103.100 Millions	$ 445 Millions
Henry Schein Inc	4.68	$ 9,342.000 Millions	$ 1,997 Millions
Guardant Health Inc	4.53	$ 413.947 Millions	$ 91 Millions
Idexx Laboratories Inc	4.44	$ 1,714.440 Millions	$ 386 Millions
Adc Therapeutics Sa	4.17	$ 5.806 Millions	$ 1 Millions
Scilex Holding Company	4.08	$ 14.867 Millions	$ 4 Millions

Date modified: 2026-08-14T20:25:15+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.